Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  IGI LABORIGI       

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 57,4 M
EBIT 2015 8,25 M
Net income 2015 6,34 M
Finance 2015 29,1 M
Yield 2015 -
Sales 2016 87,6 M
EBIT 2016 23,3 M
Net income 2016 15,1 M
Finance 2016 5,00 M
Yield 2016 -
PER 2015 127,71
PER 2016 47,05
EV / Sales 2015 7,72x
EV / Sales 2016 5,34x
Capitalization 472 M
More Financials
Company
IGI Laboratories, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's... 
Sector
Pharmaceuticals
Calendar
04/28 | 04:15pmEarnings Call
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating :
More Ratings
Latest news on IGI LABORIGI
08:01a IGI LABORATORIES : To Hold Conference Call For 1st Quarter 2015 Results
04/24 IGI LABORATORIES : To Hold Conference Call For 1st Quarter 2015 Results
04/13 IGI LABORATORIES : To Present At 14th Annual Needham Healthcare Conference On Ap..
03/26 IGI LABORATORIES : Announces First ANDA Submission Of 2015
03/23 IGI LABORATORIES : Appoints John Celentano to Board of Directors
03/10 IGI LABORATORIES : Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanof..
03/09 IGI LABORATORIES : To Present At 27th Annual ROTH Capital Conference On March 9,..
03/02 IGI LABORATORIES : Announces Fourth Quarter And Year End 2014 Results
More news
Sector news : Pharmaceuticals - NEC
10:33p BIOMARIN PHARMACEUTICAL : CRY Has A Reason To Smile, MDXG Lifts Outlook, MYL Rej..
09:50pDJMylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update
06:31p MERCK : Announces Publication of Pivotal Data from Phase 3 Clinical Studies of Z..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF